JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability (Q42742767)
Jump to navigation
Jump to search
scientific article published on 14 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability |
scientific article published on 14 April 2011 |
Statements
1 reference
JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability (English)
1 reference
Magda F Morton
1 reference
Terrance D Barrett
1 reference
Jamie Freedman
1 reference
Lina Li
1 reference
Michele C Rizzolio
1 reference
Clodagh E Prendergast
1 reference
Xiaodong Wu
1 reference
Veronica Moreno
1 reference
Jayashree Pyati
1 reference
Katherine Figueroa
1 reference
Laurence Cagnon
1 reference
Guy Lagaud
1 reference
Luc Ver Donck
1 reference
Etienne Ghoos
1 reference
Brett Allison
1 reference
Michael H Rabinowitz
1 reference
Nigel P Shankley
1 reference
14 April 2011
1 reference
1 reference
Identifiers
1 reference